Zee Short Film Contest3 hrs ago
5 Stocks to Buy for Long Term: Analysts recommend 2 largecap, 3 midcap scrips priced from Rs 643; targets suggest up to 37.5% gains
- Written by ZeeBiz WebTeam
Published: Zee Business| Updated: Zee Business
Are there any fresh investment opportunities on Dalal Street? Domestic equity benchmarks are once again stuck in ranges, with the Nifty 50 having gyrated within a 250-odd point band for the month, as of August 6. The 50-blue-chip gauge has largely see-sawed within the 24,500-24,650 band during this period as investors and analysts track corporate earnings closely. Here are a few stocks that analysts have handpicked from a fundamental perspective, with targets implying potential gains to the tune of 12.6-37.5 per cent.
All images are representational. Image source: Pexels
1/6
Fundamental stock picks
1/6These five picks are:
Zydus Wellness
Sun Pharma
Shree Cement
G R Infra
Ajax Engineering
As of August 5, these stocks were priced in the range of Rs 643-30,205 on BSE.
2/6
Zydus Wellness
2/6Sharekhan has a 'buy' call on Zydus Wellness shares with a target price of Rs 2,304 apiece.
The brokerage's target implies a potential upside of 17.7 per cent from the stock's August 5 close.
3/6
Shree Cement
3/6ICICI Securities has a 'buy' rating assigned to the Shree Cement stock with a target of Rs 35,330 apiece.
This implies an upside of 15.8 per cent.
4/6
G R Infraprojects
4/6ICICI Securities has a 'buy' call on the G R Infraprojects stock with a target of Rs 1,430 per share.
The target suggests an upside of 15.6 per cent.
5/6
5/6ICICI Securities has a 'buy' call on the stock with a target of Rs 900, which implies a potential gain of 37.5 per cent.
6/6
Sun Pharma
6/6Geojit has a 'buy' call assigned to Sun Pharma shares with a target of Rs 13,780 apiece.
The brokerage's target indicates an upside of 12.6 per cent.
- 1
- 2
- 3
- 4
- 5
- 6